1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GERON CORP.
Geron Corp. XNAS: GERN

Geron Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of...

Read More
1.34 -0.03 (-2.19%)
57.05% Fall from 52W High
15.6M
XNAS Volume
High volume today

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
18.5 / 100
Momentum Score
Technically Neutral
47.7 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
4
1Yr Price target upside is 169%
5 analysts

11

S

13

W

3

O

1

T

SWOT Analysis

Geron Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..